other material
confidence high
sentiment neutral
materiality 0.45
Xenon issues 1.016M common shares on conversion of all Series 1 Preferred held by BVF Partners
Xenon Pharmaceuticals Inc.
- Converted 1,016,000 Series 1 Preferred Shares into 1,016,000 common shares.
- Transaction was exempt under Section 3(a)(9) of the Securities Act.
- No Series 1 Preferred Shares remain outstanding after the conversion.
- BVF Partners L.P. affiliated funds were the sole holders of the converted shares.